Nordic Capital invests in IntegriChain
Nordic Capital has acquired a majority stake in IntegriChain from Accel-KKR.
Headquartered in Philadelphia, US, IntegriChain is a commercialisation platform for pharmaceutical manufacturers.
Nordic Capital has acquired a majority stake in IntegriChain from Accel-KKR.
Headquartered in Philadelphia, US, IntegriChain is a commercialisation platform for pharmaceutical manufacturers.